Mediclinic Southern Africa continually endeavours to measure its care processes against global best practice and is therefore proud to announce that six of its hospitals (Mediclinic Limpopo; Mediclinic Paarl; Mediclinic Welkom; Mediclinic Hoogland; Mediclinic Stellenbosch and Mediclinic Victoria) were recently awarded the internationally recognised three-year quality assurance accreditation by the Council for Health Service Accreditation of Southern Africa (COHSASA), five of them for the second time.
This brings the total of fully accredited Mediclinic Southern Africa hospitals to 31, out of the 36 that are currently participating in the COHSASA programme. A further three are in the final stages of accreditation. “Mediclinic has the highest number of internationally accredited facilities in Southern Africa and possibly the world,” says the private hospital group’s operational business analyst, John Lawton.
The COHSASA accreditation process is an exacting self assessment and external review used by healthcare organisations to accurately assess their levels of performance in relation to established standards, and to implement ways to continually improve. More than 3000 criteria are evaluated in the survey and all services must score at least 80 out of 100. There should be no non-compliant standards or criteria that could result in serious harm or injury to patients or staff; contravention of critical laws and regulations or serious administrational, organisational or managerial problems.
“Mediclinic Southern Africa has maintained consistently high scores on the measurement criteria, thereby assuring patients that this company takes quality seriously,” says Marilyn Keegan, COHSASA communications manager.
Through quality assurance programmes such COHSASA, Mediclinic Southern Africa is able to continually interrogate ways of improving quality and efficiency to deliver cost-effective healthcare of the highest standards. This is in line with Mediclinic’s vision of becoming the international benchmark in private healthcare.